MAPS’ Policy and Advocacy team members are actively traveling around the world to educate the public about our work, which has led to current participation at the United Nations’ (UN) 62nd session of the Commission on Narcotic Drugs (CND) in Vienna, Austria to present and advocate the human right to science and research with controlled substances, alongside international allies including International Center for Ethnobotanical Education, Research and Service (ICEERS) and Science for Democracy. For more information about the UN CND, watch this video.
On March 16, 2019, MAPS Policy and Advocacy Director Natalie Lyla Ginsberg, M.S.W., represented MAPS at South by South West (SXSW) 2019 through participating in a panel discussion, The Future of Hemp and Health. In addition to this panel discussion, Natalie also collaborated with MAPS Development Officer Liana Gillooly on hosting the Psychedelic Science Meet Up at SXSW, a well-attended gathering that engaged and united the local psychedelic community.
On February 26, 2019, MAPS Policy and Advocacy Counsel Ismail Lourido Ali, J.D., spoke with Annie Oak of the Women’s Visionary Congress at Psychedelic Systems of the Future, an event hosted by Psychedelic Seminars in San Francisco, California.